Mathematical Research Data Initiative
Main page
Recent changes
Random page
SPARQL
MaRDI@GitHub
New item
Special pages
In other projects
MaRDI portal item
Discussion
View source
View history
English
Log in

Some issues for the consideration of individual bioequivalence

From MaRDI portal
Publication:4239496
Jump to:navigation, search

DOI10.1080/10543409708835167zbMATH Open1063.62589OpenAlexW2079296016WikidataQ41369488 ScholiaQ41369488MaRDI QIDQ4239496FDOQ4239496


Authors: Laszlo Endrenyi Edit this on Wikidata


Publication date: 1997

Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/10543409708835167





zbMATH Keywords

intrasubject variationdrug regulationdrug substitution


Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)


Cites Work

  • Moment-based criteria for determining bioequivalence
  • Assessment of Individual and Population Bioequivalence Using the Probability That Bioavailabilities are Similar
  • Individual bioequivalence—a regulatory update
  • Extension to the use of tolerance intervals for the assessment of individual bioequivalence






This page was built for publication: Some issues for the consideration of individual bioequivalence

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4239496)

Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Publication:4239496&oldid=18120337"
Tools
What links here
Related changes
Printable version
Permanent link
Page information
This page was last edited on 6 February 2024, at 15:42. Warning: Page may not contain recent updates.
Privacy policy
About MaRDI portal
Disclaimers
Imprint
Powered by MediaWiki